Search
Unexpected role of OTX2 drives aggressive medulloblastoma
- OPACC
- Jul 26, 2024
- 1 min read
Researchers revealed an unexpected way in which the protein OTX2 drives the progression of medulloblastoma -- the most common aggressive childhood brain cancer. The findings suggest that targeting OTX2 or its effects can have therapeutic relevance.
Recent Posts
See AllWhile the overall prevalence of comorbidities at diagnosis in pediatric patients with acute lymphoblastic leukemia (ALL) and...
The FDA has granted Rare Pediatric Disease Designation for NEO100 in the treatment of pediatric-type diffuse high-grade gliomas, a type...
Untreated growth hormone deficiency was associated with neurocognitive impairment and reduced physical functioning among adult survivors...
Comments